Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gagne

Showing results (11-20 of 344) with videos related to

Pageof 35
Sort By:
The Annals of Pharmacotherapy|March 6, 2009
Comment: pharmaceutical care for migraine and headache patients: a community-based, randomized interventionJoshua J Gagne, Vittorio Maio
Clinical Pharmacology and Therapeutics|October 23, 2019
Response to "The Self-Controlled Case Series Design as a Viable Alternative to Studying Clinically Relevant Drug Interactions"Katsiaryna Bykov, Joshua J Gagne
Pharmacoepidemiology and Drug Safety|January 3, 2013
On analyzing therapeutic ineffectiveness reportsJoshua J Gagne, Katsiaryna Bykov
Drug Safety|January 11, 2017
Generating Evidence of Clinical Outcomes of Drug-Drug InteractionsKatsiaryna Bykov, Joshua J Gagne
JAMA|February 18, 2011
How many "me-too" drugs is too many?Joshua J Gagne, Niteesh K Choudhry
The American Journal of Managed Care|January 17, 2009
Concern still warranted: medication burden and persistence with lipid-lowering drugsJennifer M Polinski, Joshua J Gagne
Journal of General Internal Medicine|January 23, 2014
SMART designs in observational studies of opioid therapy durationJohn W Jackson, Joshua J Gagne
Expert Opinion on Pharmacotherapy|August 10, 2007
Candidemia in the in-patient setting: treatment options and economicsJoshua J Gagne, Neil I Goldfarb
The American Journal of Physiology|August 1, 1989
Plasma catecholamine and glucose concentrations during hemorrhagic hypotension in anesthetized dogsR Briand, N Yamaguchi, J Gagne
Journal of General Internal Medicine|July 18, 2014
Introduction to a supplement on innovative approaches to studying health outcomes in rare diseasesAaron S Kesselheim, Joshua J Gagne
Pageof 35

Showing results (11-20 of 344) with videos related to

Sort By:
Pageof 35
The Annals of Pharmacotherapy|March 6, 2009
Comment: pharmaceutical care for migraine and headache patients: a community-based, randomized interventionJoshua J Gagne, Vittorio Maio
Clinical Pharmacology and Therapeutics|October 23, 2019
Response to "The Self-Controlled Case Series Design as a Viable Alternative to Studying Clinically Relevant Drug Interactions"Katsiaryna Bykov, Joshua J Gagne
Pharmacoepidemiology and Drug Safety|January 3, 2013
On analyzing therapeutic ineffectiveness reportsJoshua J Gagne, Katsiaryna Bykov
Drug Safety|January 11, 2017
Generating Evidence of Clinical Outcomes of Drug-Drug InteractionsKatsiaryna Bykov, Joshua J Gagne
JAMA|February 18, 2011
How many "me-too" drugs is too many?Joshua J Gagne, Niteesh K Choudhry
The American Journal of Managed Care|January 17, 2009
Concern still warranted: medication burden and persistence with lipid-lowering drugsJennifer M Polinski, Joshua J Gagne
Journal of General Internal Medicine|January 23, 2014
SMART designs in observational studies of opioid therapy durationJohn W Jackson, Joshua J Gagne
Expert Opinion on Pharmacotherapy|August 10, 2007
Candidemia in the in-patient setting: treatment options and economicsJoshua J Gagne, Neil I Goldfarb
The American Journal of Physiology|August 1, 1989
Plasma catecholamine and glucose concentrations during hemorrhagic hypotension in anesthetized dogsR Briand, N Yamaguchi, J Gagne
Journal of General Internal Medicine|July 18, 2014
Introduction to a supplement on innovative approaches to studying health outcomes in rare diseasesAaron S Kesselheim, Joshua J Gagne
Pageof 35